Announcing the new Revolution Contraceptives website

Linda Brent, PhD

Executive Director, Parsemus Foundation

The Parsemus Foundation began working on a new male contraceptive called Vasalgel a number of years ago. In 2013, Revolution Contraceptives was formed as a social venture company to develop Vasalgel and bring it to market.

Revolution Contraceptives has grown over the last couple of years to meet the increasingly diverse and complex demands related to moving a product through the R&D and preclinical pipeline toward human clinical trials. To better serve the increasing number of people who are interested in Vasalgel, Revolution Contraceptives now has its own website:

While the Parsemus website includes Vasalgel as one of its main programs – and donors can continue to contribute to Vasalgel through the Parsemus Foundation – most of the information on Vasalgel is now on the Revolution Contraceptives website. Take a look!

We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today